Wenyu Li

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Topics

Prognostic Factors

Diffuse Large B Cell Lymphoma

Top Venues

Annals of hematology

Cancer medicine

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Liu, Baijing Xia, Xinmiao Jiang, Lixue Cao, Zhihui Xi, Liting Liang, Shaojun Zhang, Hui Zhang, Wenyu Li
Single-cell landscape reveals the immune heterogeneity of bone marrow involvement in peripheral T-cell lymphoma. Cancer science 115 (8) (2024)
Jun Liu, Baijing Xia, Xinmiao Jiang, Lixue Cao, Zhihui Xi, Liting Liang, Shaojun Zhang, Hui Zhang, Wenyu Li
Single-cell landscape reveals the immune heterogeneity of bone marrow involvement in peripheral T-cell lymphoma. Cancer science (2024)
Jun Liu, Baijing Xia, Xinmiao Jiang, Lixue Cao, Zhihui Xi, Liting Liang, Shaojun Zhang, Hui Zhang, Wenyu Li
Single-cell landscape reveals the immune heterogeneity of bone marrow involvement in peripheral T-cell lymphoma. Cancer science 115 (8) (2024)
Jun Liu, Baijing Xia, Xinmiao Jiang, Lixue Cao, Zhihui Xi, Liting Liang, Shaojun Zhang, Hui Zhang, Wenyu Li
Single-cell landscape reveals the immune heterogeneity of bone marrow involvement in peripheral T-cell lymphoma. Cancer science 115 (8) (2024)
Ning Wang, Zhenxian Mo, Lu Pan, Minhua Zhou, Xiaolan Ye, Xinjian Liu, Xiong Cai, Changgeng Qian, Feili Chen, Yan Xiong, Fushun Fan, Wenyu Li
Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System Lymphoma. Targeted oncology (2023)
Cunte Chen, Zheng Chen, Ling Huang, Lingling Zhou, Lihua Zhu, Sichu Liu, Gengxin Luo, Wenyu Li, Chengwu Zeng, Yangqiu Li
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma. Cancer cell international 21 (1) (2021)
Feili Chen, Diwen Pang, Hanguo Guo, Qiuxiang Ou, Xue Wu, Xinmiao Jiang, Xiaojuan Wei, Sichu Liu, Ling Huang, Zhanli Liang, Dong Zhou, Wenyu Li
Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib-based combination therapy: A real-world experience of off-label ibrutinib use. Cancer medicine 9 (22) (2020)
Ling Huang, Fen Zhang, Jialong Zeng, Hanguo Guo, Sichu Liu, Xiaojuan Wei, Feili Chen, Xinmiao Jiang, Zhanli Liang, Yanhui Liu, Wenyu Li
ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population. Annals of hematology 97 (1) (2017)